πΊπΈβ‘οΈ β The Trump administration is considering temporarily allowing compounding pharmacies to sell certain previously restricted peptides while the FDA develops new regulations governing the products, according to WaPo. Health Secretary Robert F. Kennedy Jr. supports expanding access to peptides, which are increasingly marketed for longevity, physical performance and other wellness benefits. The plan has not been finalized yet. An FDA advisory panel has recommended permitting six of seven peptides under review, despite objections from agency scientists. FDA officials and medical experts have warned that many of these products lack adequate clinical evidence demonstrating their safety and effectiveness.